Original Research

Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission

Zhou M, Wang J, Li CP, Xu JY, Chen B

OncoTargets and Therapy 2020, 13:5879-5885

Published Date: 22 June 2020